Clinical Trial Update: Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the testicular safety of filgotinib in adult males with inflammatory bowel disease was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Filgotinib (filgotinib)

Snippet

Sponsor: Galapagos NV | Conditions: Inflammatory Bowel Disease | Phase 2 | Status: TERMINATED | Results posted: 2023-12-06